Stock Price Quote

SEQUENT SCIENTIFIC LTD.

NSE : SEQUENTBSE : 512529ISIN CODE : INE807F01027Industry : Pharmaceuticals & DrugsHouse : Sequent
BSE95.75-1.55 (-1.59 %)
PREV CLOSE ( ) 97.30
OPEN PRICE ( ) 98.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 58497
TODAY'S LOW / HIGH ( )94.80 98.95
52 WK LOW / HIGH ( )81.4 204.45
NSE95.75-1.6 (-1.64 %)
PREV CLOSE( ) 97.35
OPEN PRICE ( ) 97.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 95.75 (2138)
VOLUME 784089
TODAY'S LOW / HIGH( ) 94.75 97.80
52 WK LOW / HIGH ( )82 203
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-06 1985
Management Info
Kamal K Sharma - Chairman Rajaram Narayanan - Managing Director
Registered Office

Address 301, ' Dosti Pinnacle',3rd Floor, Plot No. E7,Road No. 22, Wagle Indl. Estate,
Thane,
Maharashtra-400604

Phone 022 4111 4777

Email pidsecretarial@yahoo.co.in

Website www.sequent.in

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

14Nov Sequent Scientific informs about trans
Pursuant to Regulation 30(6) of the Securities and Exchange Board of Ind..
09Nov Godrej Properties, Lupin and Wipro to
Godrej Properties (GPL) has, on outright basis, has acquired a 12-acre l..
08Nov Sequent Scientific gets nod to acquire
Sequent Scientific has received an approval for acquisition of 100% stak..
07Nov Announcement under Regulation 30 (LOD
Sequent Scientific Limited has informed the Exchange that the Board of D..
16Aug Sequent Scientific informs about earni
Pursuant to Regulation 30(6) of the Securities and Exchange Board of Ind..

Financials

in Millions
QTR Sep 22 ANNUAL 22
Net Profit-40.5147.99
Gross Profit -56.77 156.9
Operating Profit -28.53268.93
Net Sales 542.312196.26

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  20372.25 (0.81%)
M.Cap ( in Cr)43289.61
Themis Medicare (BSE)
peergroup  1124.15 (5.44%)
M.Cap ( in Cr)1034.25
Samrat Pharmachem (BSE)
peergroup  868.80 (5.00%)
M.Cap ( in Cr)268.43
Astrazeneca Pharma I (BSE)
peergroup  3374.55 (1.14%)
M.Cap ( in Cr)8436.38
Procter&Gamble Healt (BSE)
peergroup  4188.00 (0.69%)
M.Cap ( in Cr)6951.82

Shareholding Pattern

PROMOTERS 52.79%
NON-INSTITUTION 37.86%
FI/BANKS/INSURANCE 1.22%
MUTUAL FUNDS/UTI 0.45%
GOVERNMENT 0%
FII 0%

About Sequent Scientific Ltd.

Sequent Scientific Ltd. was incorporated in the year 1985. Its today's share price is 95.75. Its current market capitalisation stands at Rs 2388.33 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2203.25 Cr and Total Income of Rs.2584.87 Cr. The company's management includes Krunal Shah, Milind Sarwate, Neeraj Bharadwaj, Gregory John Andrews, Fabian Kausche, Kausalya Santhanam, Kamal K Sharma, Sharat Narasapur, Rajaram Narayanan, Rahul Mukim.

It is listed on the BSE with a BSE Code of 512529 , NSE with an NSE Symbol of SEQUENT and ISIN of INE807F01027. It's Registered office is at 301, ' Dosti Pinnacle',3rd Floor, Plot No. E7,Road No. 22, Wagle Indl. EstateThane-400604, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells, Deloittee Haskins & Sells, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)